|
|
Post by vissertrades on Oct 23, 2015 13:00:20 GMT -5
Examining companies’ benefits from dual listing on NASDAQ and TASE Hauser Shmuel & Rita Yankilovich (June 2007) Abstract In 2000, the Securities Law was amended to encourage dual listing on the TASE of Israeli companies listed in the US, by exempting these companies from the burden of additional reporting to the ISA. The implication of this exemption is reliance on SEC supervision, with no added costs for dual listing. Since then, over 30 Israeli companies listed on NASDAQ decided to additionally list their shares on the TASE. In this study, we examine the effects of dual listing on share prices and liquidity. Our findings are: (1) the trading volume in the shares of dual listed companies increased by 123% on average. (2) The shares’ increased liquidity had a positive impact on their prices, which rose by 9% on average in the first days following the dual listing. (3) Trading volume in Israel accounted for 42% of the total trading volume in Israel and the US, without any significant change in US trading volumes. (4) The US market has a dominant effect on dual listed share prices. The findings of this study are indicative of the positive effects of recent harmonization in international financial market regulation (Single Passport), and of its already evident impact in Europe. www.isa.gov.il/sites/ISAEng/Departments/Economic-research/Documents/IsaFile_0802156.pdf |
|
|
|
Post by benyiju on Oct 23, 2015 13:36:03 GMT -5
Thanks for posting this Visser, at least a place to start a serious conversation. Two caveats: Caveat 1) this comes from the ISA, so is not disinterested (in fact the author Shmuel Hauser is currently the Chairman of ISA). 2) it deals with Israeli cos that listed on NASDAQ, not US cos that list on TASE.
|
|
|
|
Post by mnholdem on Oct 23, 2015 13:48:27 GMT -5
Nice find, visser!
Now let's get MannKind on the Hang Seng (China) and Nikkei (Japan) exchanges.  |
|
|
|
Post by vissertrades on Oct 23, 2015 14:05:31 GMT -5
Funnny, could have opposite effect on US companies listed on TASE. Mannkind sick stock effect... Who knows whats going on! I recall Minimed investors feeling the same way before it was sold - Dazed and confused!
|
|
|
|
Post by afrizzle on Oct 23, 2015 14:50:36 GMT -5
It seems to me this only helps longs.
Many savers buy indexes on autopilot, direct deposit and transaction on a schedule or out of their paycheck
This is new potential baseline demand
|
|
|
|
Post by kdaddyfresh2000 on Oct 23, 2015 14:50:43 GMT -5
Funnny, could have opposite effect on US companies listed on TASE. Mannkind sick stock effect... Who knows whats going on! I recall Minimed investors feeling the same way before it was sold - Dazed and confused! Can you give some details about the sentiment and events re Minimed? It might be a morale booster and give some good insight/perspective.... |
|
|
|
Post by vissertrades on Oct 23, 2015 16:44:39 GMT -5
Just that I recall comments from some that were invested in minimed stating no one knew what was going on and then bam a buyout...
|
|
|
|
Post by bradleysbest on Oct 23, 2015 17:25:31 GMT -5
I would be just fine with a 1 punch KO of the shorts! The punch you do not see is the best one.....
|
|
|
|
Post by kc on Oct 23, 2015 18:09:58 GMT -5
Is this the reason for the small increase this week in sp. Seems like a very calculated move on the chess board. Although I don't truly don't understand the ramifications I like it. Look forward to reading some posts with more knowledge about the affect this could have... Love trading on Sunday. This add a new dynamic to the situation. |
|
|
|
Post by kc on Oct 23, 2015 18:10:39 GMT -5
Wasn't MNKD hopeful to have AFrezza in Isreal? One of the first countries outside of the U.S. maybe there is a conncection? The new listing also offers an opportunity to expand and diversify our shareholder base by increasing our exposure and improving our accessibility to Israeli investors," said Hakan Edstrom, President and CEO of MannKind. "This listing is also an extension of the long-standing relationship between our Executive Chairman, Alfred Mann, and the Israeli biotechnology industry, including the Alfred Mann Institute at the Technion (Israel Institute of Technology)." |
|
|
|
Post by babaoriley on Oct 23, 2015 18:23:23 GMT -5
Wasn't MNKD hopeful to have AFrezza in Isreal? One of the first countries outside of the U.S. maybe there is a conncection? The new listing also offers an opportunity to expand and diversify our shareholder base by increasing our exposure and improving our accessibility to Israeli investors," said Hakan Edstrom, President and CEO of MannKind. "This listing is also an extension of the long-standing relationship between our Executive Chairman, Alfred Mann, and the Israeli biotechnology industry, including the Alfred Mann Institute at the Technion (Israel Institute of Technology)." Hey, if Hakan said it, it must be on the money!! |
|
|
|
Post by mnholdem on Oct 23, 2015 18:45:16 GMT -5
An agora for your thoughts, baba.
|
|
|
|
Post by ezrasfund on Oct 23, 2015 19:01:49 GMT -5
Still wondering which Middle Eastern country would like to buy $200 million of Afrezza? It is Saudi Arabia. Guess who is having a big conference coming up soon and included Afrezza? I cannot believe the people on this board are so clueless about political realities in the middle east. "This listing is also an extension of the long-standing relationship between our Executive Chairman, Alfred Mann, and the Israeli biotechnology industry, including the Alfred Mann Institute at the Technion (Israel Institute of Technology)." |
|
|
|
Post by longstocking on Oct 23, 2015 20:51:54 GMT -5
Perhaps you could enlighten us. Sounds like you've been there. Or are you basing your opinion of the political "realities" from info gleaned from the likes of Fox news or MSNBC, etc.?
|
|
|
|
Post by obamayoumama on Oct 23, 2015 21:17:17 GMT -5
It is Saudi Arabia. Guess who is having a big conference coming up soon and included Afrezza? I cannot believe the people on this board are so clueless about political realities in the middle east. "This listing is also an extension of the long-standing relationship between our Executive Chairman, Alfred Mann, and the Israeli biotechnology industry, including the Alfred Mann Institute at the Technion (Israel Institute of Technology)." My statement was from Matt. Alfred Mann got a call from the Saudi Prince before Afrezza was approved stating that once Afrezza was approved they would buy $200 million worth of Afrezza. I asked why haven't they taken the Prince up on his offer, and Matt said that SNY is in charge of sales and they are having a JV meeting this month on the global plans. SNY/MNKD are 6 chess moves ahead, which countries do they introduce Afrezza to, and what is the optimal order for the Global roll out. |
|
